Imaging Features of Pulmonary Immune-related Adverse Events.

Détails

ID Serval
serval:BIB_42CE5369FFE3
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Imaging Features of Pulmonary Immune-related Adverse Events.
Périodique
Journal of thoracic oncology
Auteur⸱e⸱s
Pozzessere C., Lazor R., Jumeau R., Peters S., Prior J.O., Beigelman-Aubry C.
ISSN
1556-1380 (Electronic)
ISSN-L
1556-0864
Statut éditorial
Publié
Date de publication
09/2021
Peer-reviewed
Oui
Volume
16
Numéro
9
Pages
1449-1460
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
Pulmonary immune-related adverse events represent rare but potentially severe side effects of immunotherapies. Diagnosis is often challenging, as symptoms and imaging features are not specific and may mimic other lung diseases, thus potentially delaying appropriate patient management. In this setting, an accurate imaging evaluation is essential for a prompt detection and correct management of these drug-induced lung diseases. The purpose of this article is to review the different types of pulmonary immune-related adverse events, describe their imaging characteristics on both high-resolution computed tomography and positron emission tomography/computed tomography and stress their underlying diagnostic challenge by presenting the mimickers.
Mots-clé
CTLA-4 Antigen, Humans, Immunotherapy, Lung, Lung Neoplasms/diagnostic imaging, Programmed Cell Death 1 Receptor, CTLA-4 antigen, Drug-related side effects and adverse reactions, Pneumonitis, Programmed cell death 1 receptor
Pubmed
Web of science
Open Access
Oui
Création de la notice
15/06/2021 16:12
Dernière modification de la notice
19/07/2023 6:55
Données d'usage